3.94 +0.05 (1.32%)
CRME
Stock Details
Last Trade:3.94 Change:+0.05 (1.32%) Prev Close:3.89 Open: 3.79 Days Range:3.75 – 4.00 52 Week Range: 2.57 - 12.77 Volume:286492 P/E: N/AEPS:0.00
View AllRecent Alerts 07/04/09
Recent Alert on 05/19/09 at 9:16am
Cardiome (CRME) Announces That Collaboration and License Agreement with Merck & Co. (MRK)
Cardiome (CRME) Announces That Collaboration and License Agreement with Merck & Co. (MRK)
Cardiome Pharma Corp. (NASDAQ: CRME) announced that the waiting period under the Hart-Scott-Rodino Act for the collaboration and license agreement with Merck & Co. (NYSE: MRK) and a Merck affiliate for development and commercialization of... Read More
Recent Alert on 05/19/09 at 9:16am
Cardiome (CRME) Announces That Collaboration and License Agreement with Merck & Co. (MRK)
Cardiome (CRME) Announces That Collaboration and License Agreement with Merck & Co. (MRK)
Recent Alert on 04/09/09 at 1:07pm
Unusual 11 Mid-Day Movers 4/9: TXT, APWR, BAC, CRME Higher; FAZ, HPT, MTRX, ANF Lower
Unusual 11 Mid-Day Movers 4/9: TXT, APWR, BAC, CRME Higher; FAZ, HPT, MTRX, ANF Lower
Recent Alert on 04/09/09 at 9:45am
Morning Movers 4/9: TXT, WFC, APWR, CRME, USB, EXM, BAC, GYMB, CSH Higher; MOV, ELMG, ANF Lower
Morning Movers 4/9: TXT, WFC, APWR, CRME, USB, EXM, BAC, GYMB, CSH Higher; MOV, ELMG, ANF Lower
Recent Alert on 04/08/09 at 6:20pm
Cardiome Pharma (CRME) Signs Major License Agreement With Merck (MRK) for Vernakalant
Cardiome Pharma (CRME) Signs Major License Agreement With Merck (MRK) for Vernakalant
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 04/14/09 at 4:34am
Cardiome May See More Upside When IV Formulation Gets Clarified - RBC
Cardiome May See More Upside When IV Formulation Gets Clarified - RBC
Blog Posts on 04/12/09 at 3:39am
How Will Cardiome, Merck, Eli Lilly, and Par Pharma's Phase 3 Trials Perform?
How Will Cardiome, Merck, Eli Lilly, and Par Pharma's Phase 3 Trials Perform?

